An in-depth look into today drugs

Simple item page
dc.contributor.authorMohammad, Norsarwany
dc.date.accessioned2022-09-19T01:14:08Z
dc.date.available2022-09-19T01:14:08Z
dc.date.issued2012
dc.description.abstractThe absence of significant different in the rate and extent to which the active ingredient in pharmaceutical equivalent or pharmacologic alternatives become available at the site of drug action. To be BE, 90% confident interval with AUC and Cmax of the test drug must fall within 80% to 125% of the reference standard (innovator). Bioequivalent should be done for generic drugs.en_US
dc.identifier.urihttp://hdl.handle.net/123456789/16106
dc.language.isoenen_US
dc.publisherPusat Pengajian Sains Perubatan, Universiti Sains Malaysiaen_US
dc.subjectdrugsen_US
dc.titleAn in-depth look into today drugsen_US
dc.typeThesisen_US
Files
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Pusat Pengajian Sains Perubatan - Monograf